FDA Center for Drug Evaluation & Research Issues Warning Letter to BioMylz
July 22, 2026
July 22, 2026
WASHINGTON, July 22 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to BioMylz Pvt. Ltd. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Vasanth Samaga, Founder-Director, BioMylz Pvt. Ltd., # cj-1, Santra Magan Place Apartment off Banneraghatta Road, Doddakammanahalli, near Maruthi Dental College, Bangalore 560076, India
Issuing Office: Center for Drug Evaluation and . . .
* * *
Recipient: Mr. Vasanth Samaga, Founder-Director, BioMylz Pvt. Ltd., # cj-1, Santra Magan Place Apartment off Banneraghatta Road, Doddakammanahalli, near Maruthi Dental College, Bangalore 560076, India
Issuing Office: Center for Drug Evaluation and . . .